William E. Gannon

Dr. Gannon has approximately 30 years of industry experience including medical/pharmacovigilance monitoring, data analysis, clinical protocol and program development, as well as regulatory [NDA; BLA; ANDA; IND; IDE; PMA; 510K submissions]. Dr. Gannon has held positions in multinational Clinical Research Organizations, medical device, biotech and pharmaceutical firms. Dr. Gannon has worked in diverse therapeutic areas including respiratory, infectious disease, dermatology, oncology, neurology, cardiovascular, genitourinary, gastrointestinal, general medicine and allergy among others. Dr. Gannon has managed clinical trials and operations as well as the design of corporate and regulatory strategies, regulatory submissions and execution of Phase 1 through Phase 4 clinical trials in the U.S., Europe and Asia. He has a strong understanding of US, Canadian, EU and Japanese regulatory requirements. Dr. Gannon received his medical training and clinical work in family practice at Ross University, Case Western Reserve and George Washington University. In addition, Dr. Gannon has an MBA with a concentration in Health Services Administration from George Washington University.